Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50

Ads

You May Also Like

Surface Oncology to Present at the Baird 2018 Global Healthcare Conference

CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage ...

Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products

SAINT-GENIS-POUILLY, France, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” ...

BeyondSpring Appoints Richard J. Daly as Chief Operating Officer to Lead the Transition to Commercialization

Daly Brings Significant Commercial and Business Development Experience with Global Pharmaceutical CompaniesNEW YORK, Aug. ...